HARKE Pharma GmbH sell "Hydroxypropylcellulose low-substitued (L-HPC)"

Benefits include a wide range of types covering various applications and technologies, production per IPEC-GMP guidelines, an available Chinese DMF, improved stability of the API in the finished dosage form enabling smaller tablets, full order flexibility with regular European stock and low MOQ, and extensive experience backed by detailed technical data and formulation guidance. Applications include binding (wet and dry granulation), disintegration, and anti-capping.